Advaxis Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting Posted on 2021-05-192021-06-03 by maxproadmin More >>
Acepodia The Return of Jimmy Lai | Jimmy Lai, CFO, Acepodia Posted on 2021-05-192021-06-03 by maxproadmin More >>
Acepodia Acepodia Presents Data on its Allogeneic Natural Killer-Like Gamma-Delta T Cell Therapy, ACE1831, in Development for Hematological Cancers Posted on 2021-05-192021-06-03 by maxproadmin More >>
ACT Genomics ACT Genomics signs MOU with HKU SPACE on Training Healthcare Professionals in the Field of Genomics and Molecular Technology Posted on 2021-05-132021-06-03 by maxproadmin More >>
Acepodia Acepodia Appoints Thorsten Graef, M.D., Ph.D., as Chief Medical Officer and Michael Brock as Chief Strategy Officer Posted on 2021-05-112021-06-03 by maxproadmin More >>
Arthrosi Arthrosi’s New Molecule AR882 for Gout Shows Blockbuster-Potential Posted on 2021-05-102021-06-03 by maxproadmin More >>